RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

The CACHE (Critical Assessment of Computational Hit-Finding Experiments) Challenge has spurred more new research —this time ...

Researchers unexpectedly found traces of cocaine in the mummified brain tissue of 17th-century people buried in a crypt in ...

The Pharmaceutical Programs segment includes treatments using small drug molecules that bind to the melanocortin receptors on human cells and affect skin pigmentation and other initiatives. The ...

17 news release. Chippenham, England-based Vectura specializes in inhalation drug device design and formulation for dry ...

AC Immune presented preclinical data on a new class of antibody-drug conjugates that the biotech thinks has “landmark” ...

Integral Molecular, a leader in antibody discovery and characterization, has published new research in the journal mAbs, ...

Molex has entered an agreement to acquire UK-based inhalation drug device design and formulation company Vectura Group, via ...

One of the most exciting aspects of this discovery is its potential to revolutionize drug development. The ability to ...

Thus, this binding reaction can be used to measure the presence or concentration of the molecules. Immunoassays are essential in many fields since they can effectively diagnose diseases, monitor drug ...